<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>8(5)</volume><submitter>Hehl L</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Common variants of the max-like protein X (MLX)-interacting protein-like (MLXIPL) gene, encoding the transcription factor carbohydrate-responsive element-binding protein, have been shown to be associated with plasma triglyceride levels. However, the role of these variants in steatotic liver disease (SLD) is unclear.&lt;h4>Methods&lt;/h4>We used a genome-first approach to analyze a variety of metabolic phenotypes and clinical outcomes associated with a common missense variant in MLXIPL, Gln241His, in 2 large biobanks: the UK Biobank and the Penn Medicine Biobank.&lt;h4>Results&lt;/h4>Carriers of MLXIPL Gln241His were associated with significantly lower serum levels of triglycerides, apolipoprotein-B, gamma-glutamyl transferase, and alkaline phosphatase. Additionally, MLXIPL Gln241His</pubmed_abstract><journal>Hepatology communications</journal><pagination>e0427</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12333743</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A genome-first approach to variants in MLXIPL and their association with hepatic steatosis and plasma lipids.</pubmed_title><pmcid>PMC12333743</pmcid><pubmed_authors>Rader DJ</pubmed_authors><pubmed_authors>Trautwein C</pubmed_authors><pubmed_authors>Vell MS</pubmed_authors><pubmed_authors>Schneider CV</pubmed_authors><pubmed_authors>Vujkovic M</pubmed_authors><pubmed_authors>Creasy KT</pubmed_authors><pubmed_authors>Seeling KS</pubmed_authors><pubmed_authors>Vitali C</pubmed_authors><pubmed_authors>Hehl L</pubmed_authors><pubmed_authors>Scorletti E</pubmed_authors><pubmed_authors>Conlon D</pubmed_authors><pubmed_authors>Zandvakili I</pubmed_authors><pubmed_authors>Regeneron Genetics Center</pubmed_authors><pubmed_authors>Rendel MD</pubmed_authors><pubmed_authors>Schneider KM</pubmed_authors></additional><is_claimable>false</is_claimable><name>A genome-first approach to variants in MLXIPL and their association with hepatic steatosis and plasma lipids.</name><description>&lt;h4>Background&lt;/h4>Common variants of the max-like protein X (MLX)-interacting protein-like (MLXIPL) gene, encoding the transcription factor carbohydrate-responsive element-binding protein, have been shown to be associated with plasma triglyceride levels. However, the role of these variants in steatotic liver disease (SLD) is unclear.&lt;h4>Methods&lt;/h4>We used a genome-first approach to analyze a variety of metabolic phenotypes and clinical outcomes associated with a common missense variant in MLXIPL, Gln241His, in 2 large biobanks: the UK Biobank and the Penn Medicine Biobank.&lt;h4>Results&lt;/h4>Carriers of MLXIPL Gln241His were associated with significantly lower serum levels of triglycerides, apolipoprotein-B, gamma-glutamyl transferase, and alkaline phosphatase. Additionally, MLXIPL Gln241His</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 May</publication><modification>2026-04-15T19:17:02.702Z</modification><creation>2026-04-07T14:01:13.515Z</creation></dates><accession>S-EPMC12333743</accession><cross_references><pubmed>38668731</pubmed><doi>10.1097/HC9.0000000000000427</doi></cross_references></HashMap>